Infographic | March 16, 2022

Use Of Preferred Providers Among Small Molecule Outsourcers

Source: ISR Reports

In Q32021, ISR surveyed outsourcers of small molecule API and outsourcers of small molecule drug product to ask whether their company uses a preferred providers list of contract manufacturers for outsourced manufacturing. The data show use of preferred providers is slightly more common for small molecule API than small molecule drug product manufacturing (56% vs. 51%). To learn more, follow the links to the Small Molecule API and the Small Molecule Drug Product report previews.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online